61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Intellia Therapeutics Inc
Closed
Sector Healthcare
14.29 3.63
Overview
Share price change
24h
Min
14.1
Max
14.36
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +260.35 upside |
Next Earnings | 20 Feb 2025 |
|---|
News Sentiment
By Acuity
50%
50%
176 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Intellia Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Intellia Therapeutics Inc Forecast
Price Target
By TipRanks
260.35% upside
12 Months Forecast
Average 51.53 USD 260.35%
High 91 USD
Low 14 USD
Based on 22 Wall Street analysts offering 12 month price targets forIntellia Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
176 / 392 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
$
